These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A model of polycystic kidney disease in SBM transgenic mice. Trudel M; D'Agati V Contrib Nephrol; 1992; 97():47-59. PubMed ID: 1321706 [No Abstract] [Full Text] [Related]
6. Cell biology of human autosomal dominant polycystic kidney disease. Wilson PD Semin Nephrol; 1991 Nov; 11(6):607-16. PubMed ID: 1662822 [No Abstract] [Full Text] [Related]
8. Increased activity of activator protein-1 transcription factor components ATF2, c-Jun, and c-Fos in human and mouse autosomal dominant polycystic kidney disease. Le NH; van der Wal A; van der Bent P; Lantinga-van Leeuwen IS; Breuning MH; van Dam H; de Heer E; Peters DJ J Am Soc Nephrol; 2005 Sep; 16(9):2724-31. PubMed ID: 16049073 [TBL] [Abstract][Full Text] [Related]
9. The vasculopathy of autosomal dominant polycystic kidney disease: insights from animal models. Arnaout MA Kidney Int; 2000 Dec; 58(6):2599-610. PubMed ID: 11115102 [No Abstract] [Full Text] [Related]
10. Imaging progression in polycystic kidney disease. Perrone R N Engl J Med; 2006 May; 354(20):2181-3. PubMed ID: 16707757 [No Abstract] [Full Text] [Related]
11. Kidney function and volume progression in unilateral autosomal dominant polycystic kidney disease with contralateral renal agenesis or hypoplasia: a case series. Poster D; Kistler AD; Krauer F; Blumenfeld JD; Rennert H; Weishaupt D; Wüthrich RP; Serra AL Am J Kidney Dis; 2009 Sep; 54(3):450-8. PubMed ID: 19515475 [TBL] [Abstract][Full Text] [Related]
12. Autosomal dominant polycystic disease: more than just empty space. Yee J Adv Chronic Kidney Dis; 2010 Mar; 17(2):113-4. PubMed ID: 20219613 [No Abstract] [Full Text] [Related]
14. The pck rat: a new model that resembles human autosomal dominant polycystic kidney and liver disease. Lager DJ; Qian Q; Bengal RJ; Ishibashi M; Torres VE Kidney Int; 2001 Jan; 59(1):126-36. PubMed ID: 11135065 [TBL] [Abstract][Full Text] [Related]
15. Cyst expansion and regression in a mouse model of polycystic kidney disease. Happé H; van der Wal AM; Salvatori DC; Leonhard WN; Breuning MH; de Heer E; Peters DJ Kidney Int; 2013 Jun; 83(6):1099-108. PubMed ID: 23466997 [TBL] [Abstract][Full Text] [Related]
16. Dose-Titrated Vasopressin V2 Receptor Antagonist Improves Renoprotection in a Mouse Model for Autosomal Dominant Polycystic Kidney Disease. Zittema D; Versteeg IB; Gansevoort RT; van Goor H; de Heer E; Veraar KA; Peters DJ; Meijer E Am J Nephrol; 2016; 44(3):194-203. PubMed ID: 27578560 [TBL] [Abstract][Full Text] [Related]
17. [Autosomal dominant polycystic kidney]. Jorge Adad S; Estevão Barbosa M; Fácio Luíz JM; Furlan Rodrigues MC; Iwamoto S Rev Hosp Clin Fac Med Sao Paulo; 1996; 51(1):18-20. PubMed ID: 8762650 [TBL] [Abstract][Full Text] [Related]
19. Cystic changes of breast in a family with autosomal dominant polycystic kidney disease. Maleki D; Ghafari A Iran J Kidney Dis; 2009 Oct; 3(4):246-8. PubMed ID: 19841531 [TBL] [Abstract][Full Text] [Related]
20. Polycystic kidney disease in a Neva Masquerade cat. Jasik A; Kulesza M J Small Anim Pract; 2014 Jul; 55(7):387. PubMed ID: 24905486 [No Abstract] [Full Text] [Related] [Next] [New Search]